CHICAGO — Trammell Crow Co. (TCC), a Texas-based developer, has unveiled plans for Fulton Labs, a 423,454-square-foot life science facility in the Fulton Market neighborhood of Chicago.
Located at 400 N. Aberdeen St., Fulton Labs will span 16 floors, with 12 floors of wet or dry lab space, dependent on the tenant’s needs. The lab space will be equipped for drug, chemical and biological testing as well as digital research and analysis.
The facility’s 34,000-square-foot, column-free floor plates will be able to accommodate small startups as well as multi-floor tenants. The building will also feature passenger and freight elevators, as well as chemical and equipment storage space for tenants.
“With Fulton Labs’ advanced research and development infrastructure, flexible lab spaces, and full floor launchpad for early stage companies, we are confident that this facility will help to promote growth in the Midwest’s life science industry,” says Grady Hamilton, managing director of TCC’s Midwest Business Unit.
The building will feature 35,000 square feet of amenity space, which will include a health and wellness center, a 190-person collaboration center, a rooftop fire lounge and two private balconies per floor.
The property will offer access to interstates 90, 94 and 290, as well as multiple public transit stations. The Fulton Market neighborhood a rapidly developing commercial hub in Chicago, with several life science developments and more than 10,000 new residences currently under construction.
Construction of Fulton Labs is slated for completion in the fourth quarter of 2021.
TCC is an independently operated subsidiary of CBRE Group Inc. The company has developed or acquired approximately 2,700 buildings since its founding in 1948.
— Alex Patton